ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, today announced that it will present at the 5th Annual
Canaccord Genuity Cardiovascular, Diabetes and Obesity Conference, to be
held December 7-8, 2010, at the Nikko Hotel in San Francisco.
On Tuesday, December 7, at 2:30 p.m. PT, AngioDynamics' President and
Chief Executive Officer Jan Keltjens will review the Company's business
strategy and recent corporate developments.
To access the webcast during or after the event, please visit the
investor relations portion of the Company's website at: http://investors.angiodynamics.com.
The replay will be available for 15 days after the event.
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. AngioDynamics' diverse product lines include market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
D. Joseph Gersuk,
CFO, 800-772-6446 x1608
Doug Sherk / Greg Gin,
Source: AngioDynamics, Inc.
News Provided by Acquire Media